The cost effectiveness of Naltrexone added to cognitive-behavioral therapy in the treatment of alcohol dependence
Data(s) |
01/04/2009
|
---|---|
Resumo |
he purpose of this study was to evaluate the comparative cost of treating alcohol dependence with either cognitive behavioral therapy (CBT) alone or CBT combined with naltrexone (CBT+naltrexone). Two hundred ninety-eight outpatients dependent on alcohol who were consecutively treated for alcohol dependence participated in this study. One hundred seven (36%) patients received adjunctive pharmacotherapy (CBT+naltrexone). The Drug Abuse Treatment Cost Analysis Program was used to estimate treatment costs. Adjunctive pharmacotherapy (CBT+naltrexone) introduced an additional treatment cost and was 54% more expensive than CBT alone. When treatment abstinence rates (36.1% CBT; 62.6% CBT+naltrexone) were applied to cost effectiveness ratios, CBT+naltrexone demonstrated an advantage over CBT alone. There were no differences between groups on a preference-based health measure (SF-6D). In this treatment center, to achieve 100 abstainers over a 12-week program, 280 patients require CBT compared with 160 CBT+naltrexone. The dominant choice was CBT+naltrexone based on modest economic advantages and significant efficiencies in the numbers needed to treat. |
Identificador | |
Publicador |
Routledge |
Relação |
DOI:10.1080/10550880902772456 Walters, David, Connors, Jason, Feeney, Gerald, & Young, Ross McD. (2009) The cost effectiveness of Naltrexone added to cognitive-behavioral therapy in the treatment of alcohol dependence. Journal of Addictive Diseases, 28(2), pp. 137-144. |
Fonte |
Faculty of Health; Institute of Health and Biomedical Innovation; School of Psychology & Counselling |
Palavras-Chave | #110319 Psychiatry (incl. Psychotherapy) #Cost-Effectiveness #CBT #Alcohol Treatment #Naltrexone |
Tipo |
Journal Article |